Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical trial NCT02836418 · COMPLETED
Trial details
- NCT number
- NCT02836418
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-13
- Primary completion
- 2017-04-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.